Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASMPT's Total Liabilities for the quarter that ended in Mar. 2026 was HK$0 Mil.
ASMPT's quarterly Total Liabilities
increased
from Sep. 2025 (HK$0.00 Mil) to Dec. 2025 (HK$9,030.55 Mil) but then
declined
from Dec. 2025 (HK$9,030.55 Mil) to Mar. 2026 (HK$0.00 Mil).
ASMPT's annual Total Liabilities
increased
from Dec. 2023 (HK$8,158.89 Mil) to Dec. 2024 (HK$8,381.84 Mil) and
increased
from Dec. 2024 (HK$8,381.84 Mil) to Dec. 2025 (HK$9,030.55 Mil).
The historical data trend for ASMPT's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
ASMPT's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASMPT (HKSE:00522) has a Total Liabilities of HK$0 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ASMPT and its competitors.
Is ASMPT's Total Liabilities too high?
ASMPT's current Total Liabilities is HK$0 Mil. Overall, ASMPT has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ASMPT's Total Liabilities compare to AMAT and LRCX?
ASMPT's Total Liabilities of HK$0 Mil can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Semiconductors company?
A good Total Liabilities depends on the Semiconductors industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ASMPT and its competitors. ASMPT's current Total Liabilities is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASMPT stock overvalued right now?
Based on GuruFocus' analysis, ASMPT (HKSE:00522) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$92.83, compared to a current price of HK$151.30 — trading 63% above its estimated fair value. The current Total Liabilities is HK$0 Mil. ASMPT's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ASMPT (HKSE:00522), the current Total Liabilities is HK$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASMPT (HKSE:00522) Overvalued in 2026?
Based on GuruFocus' analysis, ASMPT stock appears to be overvalued.
The current stock price of HK$151.30 is trading 63% above its estimated GF Value™ of HK$92.83.
GuruFocus considers ASMPT to be Significantly Overvalued.
Key valuation signals for HKSE:00522:
Total Liabilities: HK$0 Mil
GF Value™: HK$92.83 vs. price of HK$151.30 (63% above fair value)
No single metric tells the full story. See the HKSE:00522 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASMPT designs, manufactures, and sells precision equipment used to assemble semiconductors and other electronic equipment. Listed on the Hong Kong Stock Exchange since 1989, ASMPT is headquartered in Hong Kong and has operations in Asia, Europe, and the US. It is the largest supplier globally in both the assembly and packaging equipment market and the surface mounted technology market. Recent growth has been driven by the growing use of advanced packaging in high end memory and logic semiconductors.
75GF Score
Get the complete analysis for HKSE:00522
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00522 has been successfully added to your 
